NO930615L - HYPOGLYCHEMIC HYDROXYLIC ACID DERIVATIVES - Google Patents

HYPOGLYCHEMIC HYDROXYLIC ACID DERIVATIVES

Info

Publication number
NO930615L
NO930615L NO93930615A NO930615A NO930615L NO 930615 L NO930615 L NO 930615L NO 93930615 A NO93930615 A NO 93930615A NO 930615 A NO930615 A NO 930615A NO 930615 L NO930615 L NO 930615L
Authority
NO
Norway
Prior art keywords
hypoglychemic
acid derivatives
hydroxylic acid
hydroxylic
benzofuranylmethyl
Prior art date
Application number
NO93930615A
Other languages
Norwegian (no)
Other versions
NO930615D0 (en
Inventor
Steven Wayne Goldstein
Ruth Elsbree Mcdermott
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO930615L publication Critical patent/NO930615L/en
Publication of NO930615D0 publication Critical patent/NO930615D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)

Abstract

Certain 1-(benzyl or 5-benzofuranylmethyl)-1-hydroxyurea derivatives are useful as hypoglycemic and hypocholesterolemic agents.
NO930615A 1990-08-23 1993-02-22 HYPOGLYCHEMIC HYDROXYLIC ACID DERIVATIVES NO930615D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57274590A 1990-08-23 1990-08-23
PCT/US1991/004352 WO1992003425A1 (en) 1990-08-23 1991-06-26 Hypoglycemic hydroxyurea derivatives

Publications (2)

Publication Number Publication Date
NO930615L true NO930615L (en) 1993-02-22
NO930615D0 NO930615D0 (en) 1993-02-22

Family

ID=24289181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930615A NO930615D0 (en) 1990-08-23 1993-02-22 HYPOGLYCHEMIC HYDROXYLIC ACID DERIVATIVES

Country Status (22)

Country Link
US (4) US5334604A (en)
EP (1) EP0544696B1 (en)
JP (1) JPH0678326B2 (en)
KR (1) KR930701420A (en)
AT (1) ATE116971T1 (en)
AU (1) AU645112B2 (en)
CA (1) CA2087437A1 (en)
DE (1) DE69106714T2 (en)
DK (1) DK0544696T3 (en)
ES (1) ES2067945T3 (en)
FI (1) FI930772A0 (en)
GR (1) GR3014913T3 (en)
HU (1) HUT70153A (en)
IE (1) IE64927B1 (en)
IL (2) IL99214A0 (en)
MX (1) MX9100804A (en)
NO (1) NO930615D0 (en)
NZ (1) NZ239514A (en)
PT (1) PT98732A (en)
TW (1) TW200470B (en)
WO (1) WO1992003425A1 (en)
ZA (1) ZA916644B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544696B1 (en) * 1990-08-23 1995-01-11 Pfizer Inc. Hypoglycemic hydroxyurea derivatives
RU2135487C1 (en) * 1993-04-30 1999-08-27 Яманоути Фармасьютикал Ко., Лтд. Bis-oxadiazolidinedione derivatives, pharmaceutical composition
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
JP3354258B2 (en) * 1993-12-03 2002-12-09 富山化学工業株式会社 New indoles or their salts
CA2157032C (en) * 1993-12-27 1999-09-28 Hisashi Shinkai Isoxazolidinedione derivative and use thereof
US5480896A (en) * 1994-01-27 1996-01-02 American Home Products Corporation Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents
RU2151145C1 (en) * 1994-04-11 2000-06-20 Санкио Компани Лимитед Intermediate compound for synthesis of heterocyclic compounds showing antidiabetic activity
US5420146A (en) * 1994-05-10 1995-05-30 American Home Products Corporation Di-oxadiazolidine derivatives as antihyperglycemic agents
US5468762A (en) * 1994-05-18 1995-11-21 American Home Products Corporation Azolidinediones as antihyperglycemic agents
US5532256A (en) * 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
US5703096A (en) * 1994-10-07 1997-12-30 Sankyo Company, Limited Oxime derivatives, their preparation and their therapeutic use
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimidazole derivatives and pharmaceutical compositions containing the same
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
EP0912562A1 (en) 1996-07-19 1999-05-06 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
EE03765B1 (en) 1996-08-19 2002-06-17 Japan Tobacco Inc. Propionic acid derivatives and their uses
CA2323889A1 (en) * 1997-03-12 1998-09-17 Robert W. Esmond A method for treating or preventing alzheimer's disease
DE19711616A1 (en) 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Improved process for the preparation of thiazolidinediones
WO1998057649A1 (en) 1997-06-18 1998-12-23 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and sulphonylurea
PT1022272E (en) 1997-10-08 2004-08-31 Sankyo Co SUBSTITUTED HETEROCYCLIC COMPOUNDS
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
ES2211053T3 (en) 1998-03-30 2004-07-01 Japan Tobacco Inc. PROCEDURE TO PRODUCE A COMPOUND OF ISOOXAZOLIDINDIONA.
JP2002528533A (en) 1998-10-29 2002-09-03 ブリストル−マイヤーズ スクイブ カンパニー Novel inhibitors of the enzyme IMPDH
AR023700A1 (en) 1998-11-12 2002-09-04 Smithkline Beecham Plc A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INSULIN SENSITIZER
ID28783A (en) 1998-11-12 2001-07-05 Smithkline Beecham Plc PHARMACEUTICAL COMPOSITION FOR MODIFICATED RELEASE FROM OTHER INSULIN PEMEKA AND ANTIDIABETES
JP4316787B2 (en) * 2000-01-11 2009-08-19 壽製薬株式会社 An ether or amide derivative, a process for producing the same, and a therapeutic agent for diabetes containing the same,
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
JPWO2002046154A1 (en) * 2000-12-05 2004-04-08 日本ケミファ株式会社 Activator of peroxisome proliferator-activated receptor δ
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3437664A (en) * 1966-03-18 1969-04-08 Velsicol Chemical Corp 1,2,4-oxadiazolidines
US3895023A (en) * 1973-02-06 1975-07-15 Du Pont Antiinflammatory 1,2,4-oxadiazolidine-3,5-diones
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4342771A (en) * 1981-01-02 1982-08-03 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4406910A (en) * 1981-06-15 1983-09-27 Shell Oil Company Pesticidal 3-(2,3-dihydro-2-alkylbenzofuran-7-yl)-5-(R-oxy)-1,3,4-oxadiazol-2(3H)-ones
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
CN1003445B (en) * 1984-10-03 1989-03-01 武田药品工业株式会社 The preparation method of thiazolidine diketone derivative
US4703052A (en) * 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones
US4758263A (en) * 1986-10-27 1988-07-19 Sandoz Ltd. 2-(2,5-difluorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5 diones
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
US4895953A (en) * 1987-09-30 1990-01-23 American Home Products Corporation 2-Aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008652A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
EP0544696B1 (en) * 1990-08-23 1995-01-11 Pfizer Inc. Hypoglycemic hydroxyurea derivatives
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
US5480896A (en) * 1994-01-27 1996-01-02 American Home Products Corporation Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents

Also Published As

Publication number Publication date
MX9100804A (en) 1992-04-01
DE69106714T2 (en) 1995-05-11
EP0544696B1 (en) 1995-01-11
CA2087437A1 (en) 1992-02-24
FI930772A (en) 1993-02-22
IE912971A1 (en) 1992-02-26
KR930701420A (en) 1993-06-11
FI930772A0 (en) 1993-02-22
AU645112B2 (en) 1994-01-06
US5763467A (en) 1998-06-09
IE64927B1 (en) 1995-09-20
US5463070A (en) 1995-10-31
US5646168A (en) 1997-07-08
HU9300486D0 (en) 1993-05-28
PT98732A (en) 1992-07-31
GR3014913T3 (en) 1995-05-31
JPH05508654A (en) 1993-12-02
ZA916644B (en) 1993-04-28
TW200470B (en) 1993-02-21
ES2067945T3 (en) 1995-04-01
IL113141A0 (en) 1995-06-29
US5334604A (en) 1994-08-02
HUT70153A (en) 1995-09-28
DE69106714D1 (en) 1995-02-23
JPH0678326B2 (en) 1994-10-05
EP0544696A1 (en) 1993-06-09
AU8235391A (en) 1992-03-17
NO930615D0 (en) 1993-02-22
NZ239514A (en) 1993-10-26
WO1992003425A1 (en) 1992-03-05
IL99214A0 (en) 1992-07-15
ATE116971T1 (en) 1995-01-15
DK0544696T3 (en) 1995-06-06

Similar Documents

Publication Publication Date Title
NO930615L (en) HYPOGLYCHEMIC HYDROXYLIC ACID DERIVATIVES
MX173722B (en) DYNAMICALLY ORIENTED AMPLIFIER
ATE238790T1 (en) USE OF PRAMIPEXOLE AS A NEUROPROTECTIVE AGENT
DE69110595D1 (en) Amplifier circuitry.
DK0425650T3 (en) Anti-inflammatory 4-aminophenol derivatives
ITTO910567A0 (en) CARBOSTYRYL DERIVATIVES.
DK0696278T3 (en) Herbicide-acting substituted 1-phenyl- or 1-pyridinylbenzotriazoles
TR199701298T1 (en) Tetralins.
DE69113856T2 (en) Amplifier.
ATE165594T1 (en) TRIARYLETHYLENE DERIVATIVES FOR THERAPEUTIC USE
ES2135535T3 (en) TIAZOLOTRIAZOL AND TIAZOLODIAZOL DERIVATIVES WITH FUNGICIDE ACTIVITY.
DE69107214D1 (en) LASER AND AMPLIFIER.
YU151991A (en) PROCEDURE FOR DESTRUCTION OF VENTURIA
DE69114949T2 (en) Push-pull power amplifier.
ES2116399T3 (en) THIAZOLIC DERIVATIVES OF ALCOXIACRILATOS WITH A FUNGICIDE ACTIVITY.
TR199701011A2 (en) 1-carb-(detia)-cephalosporin t�revleri.
FR2667779B1 (en) APN2E DIRECT MONITOR.
FI904885A (en) REGISTRATION OF ORGANIZATION FOR SPECIFICATIONS, SPECIFICALLY FOR EXTRAORDINARY IMPLEMENTATION.
NO924265L (en) POWER OR PRESSURE AMPLIFIER